Figure 2.

Determinants of monkeypox vaccination acceptance stratified by subregion in the World Health Organization European Region, 30 July–12 August 2022

ART: antiretroviral therapy; CrI: credible interval; MPX: monkeypox; PrEP: pre-exposure prophylaxis for HIV; ref.: reference category; RR: relative risk; STI: sexually transmitted infection.

For each answer, the estimated RR (with 50% and 90% CrI) are reported related to the change in MPX vaccine acceptance compared with a reference group (reported in the plot titles). Estimates are generated by models both adjusted (red points) and unadjusted (turquoise points) for the geographical heterogeneity (i.e. using or not the nested subregion and country random effects). More details about factor association by country and subregion can be found in the Supplementary Material S8, S9, S10.